TYLER COPELAND: Open Payments
NPI 1114400090 · FRIONA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$595 in 29 payments from 17 companies in 2025. Trend: 2023 $471 · 2024 $529 · 2025 $595
Food & beverage: $595
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $94 |
| Radius Health, Inc. | 3 | $87 |
| ABBVIE INC. | 4 | $74 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $49 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $40 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| Lundbeck LLC | 1 | $29 |
| SANOFI-AVENTIS U.S. LLC | 1 | $23 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
| Phathom Pharmaceuticals, Inc. | 1 | $21 |
Products named: Tymlos, CREON, XIFAXAN, MOUNJARO, JARDIANCE, REXULTI, CAPLYTA, TZIELD.
Industry payments across TX — which companies pay providers there.
